Risk factor
Very high price volatility
Profitability factor
Very favourable analyst view
About
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.
Target Price
The average target price of BICX is 0.80 and suggests 100% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
Buy
Sell